AIM ImmunoTech Inc’s recent filing unveils that its CEO & President Equels Thomas K acquired Company’s shares for reported $25000.0 on May 06 ’24. In the deal valued at $0.41 per share,61,729 shares were bought. As a result of this transaction, Equels Thomas K now holds 778,184 shares worth roughly $0.33 million.
Then, Rodino Peter W III bought 30,865 shares, generating $12,500 in total proceeds. Upon buying the shares at $0.41, the COO, Secretary, Gen. Counsel now owns 212,583 shares.
Before that, BRYAN NANCY bought 38,462 shares. AIM ImmunoTech Inc shares valued at $15,000 were divested by the Director at a price of $0.39 per share. As a result of the transaction, BRYAN NANCY now holds 38,462 shares, worth roughly $16538.66.
Price Performance Review of AIM
On Tuesday, AIM ImmunoTech Inc [AMEX:AIM] saw its stock jump 1.19% to $0.43. Over the last five days, the stock has gained 4.04%. AIM ImmunoTech Inc shares have fallen nearly -3.39% since the year began. Nevertheless, the stocks have fallen -13.18% over the past one year. While a 52-week high of $0.75 was reached on 04/11/24, a 52-week low of $0.32 was recorded on 03/14/24. SMA at 50 days reached $0.4324, while 200 days put it at $0.4848. A total of 0.46 million shares were traded, compared to the trading of 48500.0 shares in the previous session.
Levels Of Support And Resistance For AIM Stock
The 24-hour chart illustrates a support level at 0.4100, which if violated will result in even more drops to 0.3951. On the upside, there is a resistance level at 0.4499. A further resistance level may holdings at 0.4749. The Relative Strength Index (RSI) on the 14-day chart is 47.37, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0060, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 60.00%. Stochastics %K at 30.53% indicates the stock is a holding.
